Product Information
TYBLUME 0.1-0.02 MG CHEW TAB is a brand product labeled by Exeltis USA, Inc., priced at $0.8275 per EA under NDC 00642747101. Its NADAC has been published 192 times since Dec 21, 2022.
FDA first approved this application on Mar 30, 2020.
Manufacturer
Exeltis USA, Inc.NDC
00642747101
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA209405FDA Approved
3/30/2020
On Market Since
10/26/2020
Price Statistics
The NADAC for TYBLUME 0.1-0.02 MG CHEW TAB has been published 192 times since Dec 21, 2022, and over the history we have for it it has risen 10.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8275 per EA |
|---|---|
| All-time high | $0.8277 (Jul 15, 2026) |
| All-time low | $0.7466 (Dec 21, 2022) |
| 52-week high | $0.8277 |
| 52-week low | $0.7518 |
| Median price | $0.7523 |
| Average price | $0.7642 |
| Largest weekly change | +10.0% (Dec 31, 2025) |
| Weeks tracked | 192 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TYBLUME 0.1-0.02 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for TYBLUME 0.1-0.02 MG CHEW TAB, manufactured by Exeltis USA, Inc., is $0.8275 per EA (NDC 00642747101), effective Aug 19, 2026.
How has the price of TYBLUME 0.1-0.02 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for TYBLUME 0.1-0.02 MG CHEW TAB has risen 10.8%. It has been tracked across 192 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for TYBLUME 0.1-0.02 MG CHEW TAB?
Since Dec 21, 2022, the NADAC for TYBLUME 0.1-0.02 MG CHEW TAB has ranged from a low of $0.7466 (Dec 21, 2022) to a high of $0.8277 (Jul 15, 2026), with a median of $0.7523 per EA.
Are there cheaper alternatives to TYBLUME 0.1-0.02 MG CHEW TAB?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 86% below TYBLUME 0.1-0.02 MG CHEW TAB.
Who manufactures TYBLUME 0.1-0.02 MG CHEW TAB?
TYBLUME 0.1-0.02 MG CHEW TAB (NDC 00642747101) is labeled by Exeltis USA, Inc., and CMS classifies it as a brand product.